News
3h
Oprah Daily on MSNDoes Combining Hormone Therapy and a GLP-1 Boost Your Menopausal Weight Loss? Here's What the Research SaysMenopausal hormone treatment (MHT) might indirectly help with weight loss by improving sleep and redistributing abdominal fat ...
Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...
Obesity medicine expert joins an established group of science leaders in weight management, nutrition, physical activity and ...
Scripta Insights, the doctor-driven, AI-powered pharmacy navigation company that guides self-insured employers, health plans ...
The standards represent the American Diabetes Association’s effort to address the stigma that affects healthcare access, ...
Just 5 minutes of exposure to high-fat, salt, and sugar food ads can increase children’s calorie intake by 130 kcal, fueling ...
Obesity causes temporary disruptions, but not permanent structural changes, in the liver’s molecular network that regulates ...
This might be a hot take for some people, but if you're 200 pounds, you shouldn't be in a Pilates class,” Cruz said in a post ...
Skye Bioscience, Inc. (Nasdaq: SKYE) ("Skye"), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic ...
REVEAL-1 Cohort 3-month open-label data update expected in June 2025; early clinical signals reinforce Revita's potential to maintain weight loss after GLP-1 discontinuation in the real world REMAIN-1 ...
Waist-to-height ratio predicts heart failure incidence, according to research presented today at Heart Failure 2025, a scientific congress of the European Society of Cardiology (ESC).
Researchers analyzing data from 915 U.S. cities found that both obesity and impulsivity (measured by ADHD rates) are less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results